PRELUDE THERAPEUTICS INC (PRLD) Stock Balance Sheet
NASDAQ:PRLD - Nasdaq - US74065P1012 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 11.13M | 25.29M | 30.60M | 31.80M | 218.30M | |||
| Marketable Securities | 142.49M | 207.64M | 171.10M | 259.40M | N/A | |||
| Other Current Assets | 2.76M | 2.65M | 2.70M | 3.90M | 2.50M | |||
| Total Current Assets | 156.39M | 235.59M | 204.40M | 295.10M | 220.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 36.38M | 37.74M | 6.70M | 5.60M | 2.50M | |||
| Other Non-Current Assets | 4.45M | 4.34M | 9.40M | 4.30M | 300.00K | |||
| Total Non-Current Assets | 40.83M | 42.08M | 16.10M | 10.00M | 2.80M | |||
| TOTAL ASSETS | 197.22M | 277.67M | 220.50M | 305.10M | 223.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 359.00K | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 15.14M | 16.30M | 14.40M | 11.30M | 7.00M | |||
| Accounts Payable | 5.92M | 4.58M | 6.80M | 7.80M | 3.90M | |||
| Other Current Liabilities | 801.00K | 945.00K | 500.00K | 100.00K | 400.00K | |||
| Total Current Liabilities | 22.22M | 21.83M | 21.70M | 19.20M | 11.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 18.57M | 18.75M | 3.40M | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 18.57M | 18.75M | 3.40M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 40.79M | 40.58M | 25.10M | 19.20M | 11.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -554.83M | -456.39M | -334.60M | -219.10M | -107.40M | |||
| Additional Paid In Capital | 711.09M | 693.25M | 531.70M | 505.70M | 319.60M | |||
| Common Shares | 5.00K | 5.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 167.00K | 223.00K | -1.70M | -700.00K | N/A | |||
| Shares Outstanding | 42.18M | 42.06M | 47.90M | 47.60M | 43.70M | |||
| Tangible Book Value per Share | 3.71 | 5.64 | 4.08 | 6.01 | 4.86 | |||
| Total Shareholders' Equity | 156.43M | 237.09M | 195.40M | 285.90M | 212.20M | |||
| TOTAL LIABILITIES AND EQUITY | 197.22M | 277.67M | 220.50M | 305.10M | 223.60M | |||
| Statistics | ||||||||
| Current Ratio | 7.04 | 10.79 | 9.42 | 15.37 | 19.37 | |||
| Return On Assets (ROA) | -66.69% | -43.88% | -52.35% | -36.61% | -25.46% | |||
| Return On Equity (ROE) | -84.07% | -51.39% | -59.08% | -39.07% | -26.83% | |||
All data in USD , ROIC based on taxRate of 0.21